Insmed Inc (INSM)
73.15
-0.66
(-0.89%)
USD |
NASDAQ |
Nov 22, 16:00
73.10
-0.05
(-0.07%)
After-Hours: 20:00
Insmed Enterprise Value: 12.57B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 12.57B |
| November 21, 2024 | 12.69B |
| November 20, 2024 | 12.49B |
| November 19, 2024 | 12.68B |
| November 18, 2024 | 11.40B |
| November 15, 2024 | 11.35B |
| November 14, 2024 | 12.24B |
| November 13, 2024 | 12.12B |
| November 12, 2024 | 12.04B |
| November 11, 2024 | 12.34B |
| November 08, 2024 | 12.64B |
| November 07, 2024 | 12.31B |
| November 06, 2024 | 12.52B |
| November 05, 2024 | 11.88B |
| November 04, 2024 | 11.67B |
| November 01, 2024 | 11.71B |
| October 31, 2024 | 11.52B |
| October 30, 2024 | 12.06B |
| October 29, 2024 | 12.18B |
| October 28, 2024 | 12.36B |
| October 25, 2024 | 12.18B |
| October 24, 2024 | 12.31B |
| October 23, 2024 | 12.35B |
| October 22, 2024 | 12.66B |
| October 21, 2024 | 12.41B |
| Date | Value |
|---|---|
| October 18, 2024 | 12.82B |
| October 17, 2024 | 12.77B |
| October 16, 2024 | 13.20B |
| October 15, 2024 | 12.84B |
| October 14, 2024 | 12.91B |
| October 11, 2024 | 12.82B |
| October 10, 2024 | 12.31B |
| October 09, 2024 | 12.00B |
| October 08, 2024 | 12.25B |
| October 07, 2024 | 12.10B |
| October 04, 2024 | 12.41B |
| October 03, 2024 | 12.26B |
| October 02, 2024 | 12.55B |
| October 01, 2024 | 12.52B |
| September 30, 2024 | 12.54B |
| September 27, 2024 | 12.38B |
| September 26, 2024 | 12.45B |
| September 25, 2024 | 12.42B |
| September 24, 2024 | 12.41B |
| September 23, 2024 | 12.27B |
| September 20, 2024 | 12.68B |
| September 19, 2024 | 12.81B |
| September 18, 2024 | 12.45B |
| September 17, 2024 | 12.51B |
| September 16, 2024 | 12.51B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.073B
Minimum
Mar 23 2020
13.50B
Maximum
Aug 22 2024
3.966B
Average
2.998B
Median
Dec 27 2021
Enterprise Value Benchmarks
| Alnylam Pharmaceuticals Inc | 29.83B |
| Amicus Therapeutics Inc | 3.026B |
| Collegium Pharmaceutical Inc | 1.713B |
| enVVeno Medical Corp | 11.42M |
| Fulcrum Therapeutics Inc | -81.93M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -220.52M |
| Revenue (Quarterly) | 93.42M |
| Total Expenses (Quarterly) | 292.17M |
| EPS Diluted (Quarterly) | -1.27 |
| Gross Profit Margin (Quarterly) | 77.34% |
| Profit Margin (Quarterly) | -236.0% |
| Earnings Yield | -7.59% |
| Normalized Earnings Yield | -7.067 |